Hyrimoz

Medicinal product

(Invented) name

Hyrimoz

Active substance (s)

Adalimumabas

Strength

40 mg

Pharmaceutical form

injekcinis tirpalas užpildytame švirkšte

Route (s) of administration

leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AB04, Adalimumab

Marketing authorisation holder

Sandoz GmbH, Austrija

Date of authorisation

2018-07-26

Date of renewal

Documents

Hyrimoz paciento priminimo kortele vaikams.pdf

Hyrimoz paciento priminimo kortele suaugusiems.pdf

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(4)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Solution for injection in pre-filled syringe	0.8 ml
Adalimumabas	40 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
99923	86031	1086031	užpildytas švirkštas	0,8 ml su apsaugine adatos priemone N1		Receptinis	EU/1/18/1286/001	Netiekiama	-	-	No	-	-
99924	86032	1086032	užpildytas švirkštas	0,8 ml su apsaugine adatos priemone N2		Receptinis	EU/1/18/1286/002	Tiekiama	-	-	No	-	-
99925	86033	1086033	užpildytas švirkštas	0,8 ml su apsaugine adatos priemone N6 (3x2)		Receptinis	EU/1/18/1286/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2018-07-26	Registruotas